Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

894 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori.
Tsujimae M, Yamashita H, Hashimura H, Kano C, Shimoyama K, Kanamori A, Matsumoto K, Koizumi A, Momose K, Eguchi T, Fukuchi T, Fujita M, Okada A. Tsujimae M, et al. Among authors: eguchi t. Digestion. 2016;94(4):240-246. doi: 10.1159/000454762. Epub 2016 Dec 29. Digestion. 2016. PMID: 28030862 Free PMC article.
Combined pH-impedance monitoring and high-resolution manometry of Japanese patients treated with proton-pump inhibitors for persistent symptoms of non-erosive reflux disease.
Yamashita H, Ashida K, Fukuchi T, Nagatani Y, Koga H, Senda K, Eguchi T, Ubukata S, Kawaguchi S, Ueda A, Tanaka T, Ohashi R, Ito D. Yamashita H, et al. Among authors: eguchi t. J Smooth Muscle Res. 2012;48(5-6):125-35. doi: 10.1540/jsmr.48.125. J Smooth Muscle Res. 2012. PMID: 23538509 Free article. Clinical Trial.
The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors.
Yamashita H, Kanamori A, Kano C, Hashimura H, Matsumoto K, Tsujimae M, Yoshizaki T, Momose K, Obata D, Eguchi T, Fujita M, Okada A. Yamashita H, et al. Among authors: eguchi t. Digestion. 2017;96(1):52-59. doi: 10.1159/000478255. Epub 2017 Jun 30. Digestion. 2017. PMID: 28662503
Endoscopic submucosal dissection for early gastric cancer on the lesser curvature in upper third of the stomach is a risk factor for postoperative delayed gastric emptying.
Yoshizaki T, Obata D, Aoki Y, Okamoto N, Hashimura H, Kano C, Matsushita M, Kanamori A, Matsumoto K, Tsujimae M, Momose K, Eguchi T, Okuyama S, Yamashita H, Fujita M, Okada A. Yoshizaki T, et al. Among authors: eguchi t. Surg Endosc. 2018 Aug;32(8):3622-3629. doi: 10.1007/s00464-018-6091-6. Epub 2018 Feb 7. Surg Endosc. 2018. PMID: 29417229
Tumor recognition of peanut agglutinin-immobilized fluorescent nanospheres in biopsied human tissues.
Kumagai H, Yamada K, Nakai K, Kitamura T, Mohri K, Ukawa M, Tomono T, Eguchi T, Yoshizaki T, Fukuchi T, Yoshino T, Matsuura M, Tobita E, Pham W, Nakase H, Sakuma S. Kumagai H, et al. Among authors: eguchi t. Eur J Pharm Biopharm. 2019 Mar;136:29-37. doi: 10.1016/j.ejpb.2019.01.007. Epub 2019 Jan 9. Eur J Pharm Biopharm. 2019. PMID: 30639308 Free PMC article.
Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis.
Ogura T, Eguchi T, Amano M, Sano T, Nishioka N, Miyano A, Tsujimae M, Tanimura H, Yamada T, Terashima Y, Okada A, Higuchi K. Ogura T, et al. Among authors: eguchi t. Thromb Res. 2019 Apr;176:74-78. doi: 10.1016/j.thromres.2018.12.025. Epub 2019 Feb 13. Thromb Res. 2019. PMID: 30780007 Clinical Trial.
894 results